Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT00867256
Other study ID # LDMOM
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date March 31, 2004
Est. completion date April 27, 2009

Study information

Verified date September 2023
Source Corin
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To demonstrate the safety and efficacy of the Cormet Large Diameter Metal on Metal (LDMOM) Total Hip System using a composite clinical success (CCS) primary endpoint.


Description:

The results from the Cormet Large Diameter Metal on Metal (LDMOM) Total Hip System cohort will be compared to the historical results from a ceramic on ceramic (CoC) hip system cohort. The primary endpoint clinical composite success (CCS) criterion at 24 months postoperative is based on a Harris Hip Score ≥ 80 and the absence of any revision,replacement, or modification of any study component.


Recruitment information / eligibility

Status Terminated
Enrollment 195
Est. completion date April 27, 2009
Est. primary completion date October 23, 2006
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility INCLUSION CRITERIA: Patient: - is skeletally mature - is mentally capable of completing follow-up forms - will be available for follow-up out to 2 years - has a preoperative Harris Hip Score <70 points - has been deemed a candidate for hip replacement by diagnosis of the investigator. EXCLUSION CRITERIA: Patient: - has active joint infection - has had previous hip arthrodesis (fusion) - has had above knee amputation of either extremity - has active neoplastic disease - has a need for a structural bone graft in the operative side - has an ipsilateral hemi or total arthroplasty of any kind - has a nonunion or malunion of any part of the femur on operative side - has severe osteoporosis of the pelvis and/or femur as noted on standard radiograph - is a prisoner - is pregnant - is known to be allergic to implant materials - is morbidly obese.

Study Design


Intervention

Device:
Large Diameter Metal on Metal


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Corin

Outcome

Type Measure Description Time frame Safety issue
Primary Composite clinical criterion Based on Harris Hip Score = 80, and absence of any revision, replacement, or modification of any study component 24-months postoperative
See also
  Status Clinical Trial Phase
Completed NCT04226131 - MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics N/A
Completed NCT04171414 - A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis Phase 3
Completed NCT02833350 - Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA) Phase 2
Completed NCT04255134 - Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN) Phase 4
Recruiting NCT05615246 - Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
Completed NCT03248518 - Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases N/A
Completed NCT03514355 - MBSR in Rheumatoid Arthritis Patients With Controlled Disease But Persistent Depressive Symptoms N/A
Recruiting NCT06005220 - SBD121, a Synbiotic Medical Food for RA Management N/A
Recruiting NCT05451615 - Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis Phase 3
Completed NCT05054920 - Eccentric Versus Concentric Exercises for Rotator Cuff Tendinopathy in Patients With Rheumatoid Arthritis N/A
Completed NCT02037737 - Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting N/A
Recruiting NCT04079374 - Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel Phase 3
Completed NCT02504268 - Effects of Abatacept in Patients With Early Rheumatoid Arthritis Phase 3
Recruiting NCT05496855 - Remote Care in People With Rheumatoid Arthritis N/A
Completed NCT05051943 - A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
Recruiting NCT06031415 - Study of GS-0272 in Participants With Rheumatoid Arthritis Phase 1
Recruiting NCT06103773 - A Study of Single and Multiple Oral Doses of TollB-001 Phase 1
Completed NCT05999266 - The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis
Recruiting NCT05302934 - Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
Recruiting NCT04169100 - Novel Form of Acquired Long QT Syndrome Phase 4